Number of the records: 1  

Orchidaceae-Derived Anticancer Agents: A Review

  1. 1.
    0554692 - ÚVGZ 2023 RIV CH eng J - Journal Article
    Sliwinski, T. - Kowalczyk, A. - Sitarek, J. - Kolanowska, Marta
    Orchidaceae-Derived Anticancer Agents: A Review.
    Cancers (Basel). Roč. 14, č. 3 (2022), č. článku 754. E-ISSN 2072-6694
    R&D Projects: GA MŠMT(CZ) LM2018123
    Institutional support: RVO:86652079
    Keywords : lung-cancer cells * temporary immersion bioreactor * endophytic fungi * in-vitro * mesenchymal transition * dendrobium-officinale * secondary metabolites * species orchidaceae * medicinal products * inhibits migration * orchids * secondary metabolites * anticancer
    OECD category: Plant sciences, botany
    Impact factor: 5.2, year: 2022
    Method of publishing: Open access
    https://www.mdpi.com/2072-6694/14/3/754

    Simple Summary Orchids are commonly used in folk medicine for the treatment of infections and tumors but little is known about the actual chemical composition of these plants and their anticancer properties. In this paper, the most recent literature on orchid-derived bioactive substances with anticancer properties is reviewed. According to the published data, numerous species of orchids contain potential antitumor chemicals. Still, a relatively insignificant number of species of orchids have been tested for their bioactive properties and most of those studies were on Asian taxa. Broader research, 'including American and African species, as well as the correct identification of samples, is essential for evaluating the usefulness of orchids as a plant family with huge anticancer potential. Species of orchids, which belong to the largest family of flowering plants, are commonly used in folk medicine for the treatment of infections and tumors. However, little is known about the actual chemical composition of these plants and their anticancer properties. In this paper, the most recent literature on orchid-derived bioactive substances with anticancer properties is reviewed. For the assessment, previous papers on the anticancer activity of Orchidaceae published since 2015 were considered. The papers were found by exploring electronic databases. According to the available data, many species of orchids contain potential antitumor chemicals. The bioactive substances in a relatively insignificant number of orchids are identified, and most studies are on Asian taxa. Broader research on American and African species and the correct identification of samples included in the experiments are essential for evaluating the usefulness of orchids as a plant family with vast anticancer potential.
    Permanent Link: http://hdl.handle.net/11104/0330449

     
    FileDownloadSizeCommentaryVersionAccess
    Sliwinski-2022-Orchidaceae-derived-anticancer-agen.pdf71.7 MBPublisher’s postprintopen-access
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.